Security key
92243G108
Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX)
CUSIP: 92243G108
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 145,782,011
- Total 13F shares
- 136,507,040
- Share change
- +12,880,693
- Total reported value
- $15,592,116,896
- Put/Call ratio
- 57%
- Price per share
- $114.27
- Number of holders
- 325
- Value change
- +$1,498,526,683
- Number of buys
- 208
- Number of sells
- 106
Report period
Q3 2024
Institutions
325
Top holders
10
PCVX full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Vaxcyte, Inc. SEC filings
Vaxcyte, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92243G108
Recent filing periods:
Top shareholders of PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
11%
|
16,167,340
|
$1,220,795,855 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.8%
|
9,939,846
|
$750,557,773 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.7%
|
9,796,995
|
$739,771,093 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
6.1%
|
8,868,907
|
$669,721,114 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
5.6%
|
8,203,754
|
$619,465,465 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.2%
|
4,593,066
|
$346,822,414 | — | 30 Jun 2024 | |
| Capital Research Global Investors |
13F
|
Company |
2.8%
|
4,133,544
|
$312,123,907 | — | 30 Jun 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.8%
|
4,022,589
|
$303,746,000 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
3,367,147
|
$254,253,270 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.2%
|
3,173,167
|
$239,607,000 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.7%
|
2,461,775
|
$185,888,607 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
2,441,772
|
$184,412,859 | — | 30 Jun 2024 | |
| Darwin Global Management, Ltd. |
13F
|
Company |
1.4%
|
2,080,946
|
$163,916,116 | — | 30 Jun 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,934,747
|
$146,092,746 | — | 30 Jun 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
1.3%
|
1,929,348
|
$145,685,067 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.3%
|
1,862,608
|
$140,645,530 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.2%
|
1,734,821
|
$130,996,334 | — | 30 Jun 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.95%
|
1,383,131
|
$104,440,221 | — | 30 Jun 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.9%
|
1,310,436
|
$98,951,022 | — | 30 Jun 2024 | |
| Commodore Capital LP |
13F
|
Company |
0.9%
|
1,305,000
|
$98,540,550 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.83%
|
1,212,443
|
$91,551,572 | — | 30 Jun 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.75%
|
1,100,000
|
$83,061,000 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.74%
|
1,078,720
|
$81,454,147 | — | 30 Jun 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.71%
|
1,039,405
|
$78,485,472 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
0.68%
|
984,464
|
$74,336,877 | — | 30 Jun 2024 | |
| Novo Holdings A/S |
13F
|
Company |
0.65%
|
950,000
|
$71,734,500 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.64%
|
939,726
|
$70,958,710 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.6%
|
876,237
|
$66,164,656 | — | 30 Jun 2024 | |
| BRAIDWELL LP |
13F
|
Company |
0.55%
|
808,303
|
$61,034,960 | — | 30 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.55%
|
795,900
|
$60,098,409 | — | 30 Jun 2024 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
0.54%
|
793,036
|
$59,882,148 | — | 30 Jun 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.52%
|
753,240
|
$56,877,152 | — | 30 Jun 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
739,153
|
$55,813,443 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.51%
|
736,739
|
$55,631,162 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.48%
|
706,903
|
$53,378,246 | — | 30 Jun 2024 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
0.47%
|
687,908
|
$51,943,933 | — | 30 Jun 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
0.43%
|
627,202
|
$47,360,023 | — | 30 Jun 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.39%
|
575,000
|
$43,418,250 | — | 30 Jun 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.37%
|
532,904
|
$40,239,581 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.36%
|
527,594
|
$39,838,738 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.32%
|
471,281
|
$35,586,428 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.32%
|
468,579
|
$35,382,402 | — | 30 Jun 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.32%
|
462,682
|
$34,937,119 | — | 30 Jun 2024 | |
| Amundi |
13F
|
Individual |
0.3%
|
442,308
|
$33,730,408 | — | 30 Jun 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.29%
|
425,640
|
$32,140,076 | — | 30 Jun 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.29%
|
418,715
|
$31,617,170 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.28%
|
409,692
|
$30,935,850 | — | 30 Jun 2024 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.25%
|
367,217
|
$27,728,555 | — | 30 Jun 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.24%
|
343,552
|
$25,941,643 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.22%
|
325,161
|
$24,552,907 | — | 30 Jun 2024 |
Institutional Holders of Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX) as of Q3 2024
As of 30 Sep 2024,
Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX) was held by
325 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
136,507,040 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, T. Rowe Price Investment Management, Inc., and STATE STREET CORP.
This page lists
327
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
264
Q3 2024 holders
325
Holder diff
61
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.